Fasting During Neoadjuvant Chemotherapy
20
about 1.5 years
18+
Female only
1 site in OH
What this study is about
This trial is testing whether timed fasting during chemotherapy before surgery can be achieved, safe, and improve quality of life compared to standard dietary recommendations for women with epithelial ovarian cancer. Participants will either follow a fasting schedule or receive regular diet advice while undergoing neoadjuvant chemotherapy.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Intermittent Fasting
- 2.Take Neoadjuvant chemotherapy
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Chemotherapy related toxicity at Cycle 2, Chemotherapy related toxicity at Cycle 3, Chemotherapy related toxicity at Cycle 4, Chemotherapy related toxicity at post treatment, Post Quality of Life (QLQ-C30) Score Post Treatment, Pre Quality of Life (QLQ-C30) Score at Baseline
Oncology